Latest Blog Posts
Search
Sort Results
Filter by Specific Population
Filter by Topic
Filter by Resource Category
Search results
Current filters: Treatment, Hepatitis C drugs, Hepatitis C
50 search results
- Barcelona: Reports of unexpected cases of liver cancer in people undergoing treatment with DAAs
-
From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage - Looking back at liver cancer rates among people who received interferon therapy
-
From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage - Caution needed about claims of increased risk of liver cancer recurrence with use of DAAs
-
From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage - DAAs found highly tolerable (and effective) in people with mental health conditions
-
From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage - The looming arrival of Epclusa – sofosbuvir + velpatasvir
-
From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage - ABT-493 + ABT-530 in genotype 1 with previous DAA therapy failure
-
From TreatmentUpdate 215
2016, CATIE
Research summary - Webpage - ABT-493 + ABT-530 in genotypes 4, 5 and 6
-
From TreatmentUpdate 215
2016, CATIE
Research summary - Webpage - ABT-493 + ABT-530 – Eight-week treatment in genotype 3 without cirrhosis
-
From TreatmentUpdate 215
2016, CATIE
Research summary - Webpage - ABT-493 + ABT-530 in genotype 3 with cirrhosis
-
From TreatmentUpdate 215
2016, CATIE
Research summary - Webpage - ABT-493 + ABT-530 – Eight-week treatment in genotypes 1 or 2 without cirrhosis
-
From TreatmentUpdate 215
2016, CATIE
Research summary - Webpage
